Please login to the form below

Not currently logged in
Email:
Password:

Manchester

This page shows the latest Manchester news and features for those working in and with pharma, biotech and healthcare.

MSD and AstraZeneca announce phase 3 results for prostate cancer therapy

MSD and AstraZeneca announce phase 3 results for prostate cancer therapy

Noel Clarke, professor of urological oncology at The Christie/Salford Royal Hospitals and University of Manchester, PROpel trial joint chief investigator and joint lead author of the NEJM Evidence manuscript, said:

Latest news

More from news
Approximately 6 fully matching, plus 154 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 35 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 230 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Thrive Agency

We are a specialist health communication agency creating powerful and trusted content. If you’re looking for a partner to help...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....